Armata Pharmaceuticals Other Current Liabilities

Armata Pharmaceuticals (ARMP) currently reports a other current liabilities of $170M as of June 2026. That compares with $36M in the prior-year period — up 370.0% year over year. Use the charts on this page to explore Armata Pharmaceuticals's other current liabilities history and peer comparisons.

Armata Pharmaceuticals's other current liabilities increased from $36M to $170M — a 370.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Armata Pharmaceuticals reported $170M in other current liabilities as of June 2026. That compares with $36M in the prior-year period — up 370.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $170M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Armata Pharmaceuticals, and consider following ARMP for alerts when major investors trade the stock.

Armata Pharmaceuticals is classified in the Healthcare sector. On other current liabilities, it currently shows $170M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARMP with unrelated industries.